172 related articles for article (PubMed ID: 15746600)
1. [Cicatricial pemphigoid: treatment with mycophenolate mofetil].
Ingen-Housz-Oro S; Prost-Squarcioni C; Pascal F; Doan S; Brette MD; Bachelez H; Dubertret L
Ann Dermatol Venereol; 2005 Jan; 132(1):13-6. PubMed ID: 15746600
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
Megahed M; Schmiedeberg S; Becker J; Ruzicka T
J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mucous membrane pemphigoid with mycophenolate mofetil.
Nottage JM; Hammersmith KM; Murchison AP; Felipe AF; Penne R; Raber I
Cornea; 2013 Jun; 32(6):810-5. PubMed ID: 23132447
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
Saw VP; Dart JK; Rauz S; Ramsay A; Bunce C; Xing W; Maddison PG; Phillips M
Ophthalmology; 2008 Feb; 115(2):253-261.e1. PubMed ID: 17655931
[TBL] [Abstract][Full Text] [Related]
5. Treatment of mucous membrane pemphigoid with the combination of mycophenolate mofetil, dapsone, and prednisolone: a case series.
Staines K; Hampton PJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):e49-56. PubMed ID: 22727107
[TBL] [Abstract][Full Text] [Related]
6. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil as a first-line steroid-sparing agent in the treatment of pemphigus vulgaris.
Vyas N; Patel NS; Cohen GF
J Drugs Dermatol; 2013 Feb; 12(2):210-6. PubMed ID: 23377396
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone.
Rogers RS; Seehafer JR; Perry HO
J Am Acad Dermatol; 1982 Feb; 6(2):215-23. PubMed ID: 7037880
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide therapy for cicatricial pemphigoid.
Duong DJ; Moxley RT; Kellman RM; Pincus SH; Gaspari AA
J Am Acad Dermatol; 2002 Aug; 47(2 Suppl):S193-5. PubMed ID: 12140460
[TBL] [Abstract][Full Text] [Related]
10. Dapsone therapy of cicatricial pemphigoid.
Rogers RS; Mehregan DA
Semin Dermatol; 1988 Sep; 7(3):201-5. PubMed ID: 3153445
[TBL] [Abstract][Full Text] [Related]
11. Current medical treatment of ocular mucous membrane pemphigoid.
Sobolewska B; Deuter C; Zierhut M
Ocul Surf; 2013 Oct; 11(4):259-66. PubMed ID: 24112229
[TBL] [Abstract][Full Text] [Related]
12. [Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications].
Messmer EM; Hintschich CR; Partscht K; Messer G; Kampik A
Ophthalmologe; 2000 Feb; 97(2):113-20. PubMed ID: 10734737
[TBL] [Abstract][Full Text] [Related]
13. [Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid].
Zurdel J; Aboalchamat B; Zierhut M; Stübiger N; Bialasiewicz A; Engelmann K
Klin Monbl Augenheilkd; 2001 Apr; 218(4):222-8. PubMed ID: 11392266
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of the management of oral mucous membrane pemphigoid with dapsone.
Ciarrocca KN; Greenberg MS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Aug; 88(2):159-63. PubMed ID: 10468458
[TBL] [Abstract][Full Text] [Related]
15. [Ocular Cicatricial Pemphigoid - a Retrospective Study].
Szabó E; Palos M; Skalická P
Cesk Slov Oftalmol; 2016 Feb; 72(1):283-92. PubMed ID: 27041284
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid.
Doycheva D; Deuter C; Blumenstock G; Stuebiger N; Zierhut M
Ocul Immunol Inflamm; 2011 Dec; 19(6):431-8. PubMed ID: 22106912
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory blistering autoimmune diseases with mycophenolic acid.
Marzano AV; Dassoni F; Caputo R
J Dermatolog Treat; 2006; 17(6):370-6. PubMed ID: 17853312
[TBL] [Abstract][Full Text] [Related]
18. [Mucous membrane pemphigoid: a review].
Bédane C; Doffoel Hantz V
Ann Dermatol Venereol; 2011 Mar; 138(3):201-8. PubMed ID: 21397149
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
Grundmann-Kollmann M; Korting HC; Behrens S; Kaskel P; Leiter U; Krähn G; Kerscher M; Peter RU
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927
[TBL] [Abstract][Full Text] [Related]
20. [Cicatricial pemphigoid: management in stomatology].
Agbo-Godeau S; de Lima Soares P; Szpirglas H
Rev Stomatol Chir Maxillofac; 2004 Sep; 105(4):206-10. PubMed ID: 15510070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
